Jul 14, 2020

Existing drug may downgrade COVID threat to common cold level — Jerusalem study

Posted by in category: biotech/medical

An existing medicine can “downgrade” the danger-level of coronavirus to that of a common cold, a Jerusalem researcher is claiming, after testing it on infected human tissue.

Prof. Yaakov Nahmias says that his research shows that the novel coronavirus is so vicious because it causes lipids to be deposited in the lungs, and that there is a solution to undo the damage: a widely-used anti cholesterol drug called fenofibrate.

Hebrew University professor says he’s worked out what makes the raging virus so vicious, and how to fix it using an anti-cholesterol med; no human testing done yet.

Leave a reply